{
  "kind": "all",
  "value": "all",
  "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 319975,
  "page": 7403,
  "pageSize": 30,
  "pageCount": 10666,
  "rows": [
    {
      "docId": "019de076-55ad-74d3-b9a1-90902cbf53f4",
      "docSlug": "e307aa667077aaa87591999f61390379",
      "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 28 slides",
      "authorId": "mainz-biomed-nv",
      "authorName": "Mainz Biomed",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 24,
      "slideType": "team_bio",
      "function": "other",
      "notes": "The slide lists 10 advisors with their headshots, names, roles, and company logos.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-55ad-74d3-b9a1-90902cbf53f4/24",
      "deckHref": "/decks/019de076-55ad-74d3-b9a1-90902cbf53f4",
      "deckAnchorHref": "/decks/019de076-55ad-74d3-b9a1-90902cbf53f4#slide-24",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-55ad-74d3-b9a1-90902cbf53f4",
      "docSlug": "e307aa667077aaa87591999f61390379",
      "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 28 slides",
      "authorId": "mainz-biomed-nv",
      "authorName": "Mainz Biomed",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 25,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a DNA double-helix motif to represent the company's focus on molecular diagnostics.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-55ad-74d3-b9a1-90902cbf53f4/25",
      "deckHref": "/decks/019de076-55ad-74d3-b9a1-90902cbf53f4",
      "deckAnchorHref": "/decks/019de076-55ad-74d3-b9a1-90902cbf53f4#slide-25",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-55ad-74d3-b9a1-90902cbf53f4",
      "docSlug": "e307aa667077aaa87591999f61390379",
      "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 28 slides",
      "authorId": "mainz-biomed-nv",
      "authorName": "Mainz Biomed",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 26,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Includes income statement items, balance sheet data, and equity structure.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-55ad-74d3-b9a1-90902cbf53f4/26",
      "deckHref": "/decks/019de076-55ad-74d3-b9a1-90902cbf53f4",
      "deckAnchorHref": "/decks/019de076-55ad-74d3-b9a1-90902cbf53f4#slide-26",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-55ad-74d3-b9a1-90902cbf53f4",
      "docSlug": "e307aa667077aaa87591999f61390379",
      "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 28 slides",
      "authorId": "mainz-biomed-nv",
      "authorName": "Mainz Biomed",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 27,
      "slideType": "key_takeaways",
      "function": "summarize",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-55ad-74d3-b9a1-90902cbf53f4/27",
      "deckHref": "/decks/019de076-55ad-74d3-b9a1-90902cbf53f4",
      "deckAnchorHref": "/decks/019de076-55ad-74d3-b9a1-90902cbf53f4#slide-27",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-55ad-74d3-b9a1-90902cbf53f4",
      "docSlug": "e307aa667077aaa87591999f61390379",
      "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 28 slides",
      "authorId": "mainz-biomed-nv",
      "authorName": "Mainz Biomed",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 28,
      "slideType": "closing_ask",
      "function": "state_next_steps",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-55ad-74d3-b9a1-90902cbf53f4/28",
      "deckHref": "/decks/019de076-55ad-74d3-b9a1-90902cbf53f4",
      "deckAnchorHref": "/decks/019de076-55ad-74d3-b9a1-90902cbf53f4#slide-28",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce",
      "docSlug": "f071473f2318bf29da28de95df17ba43",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 1,
      "slideType": "cover",
      "function": "front_matter",
      "notes": null,
      "imagePath": "https://imgproxy.kitesheet.com/qQX9QZztvhyxOc4vLHwTipSlBVD0UZrYQvbTXC2nzak/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9mMDcxNDczZjIzMThiZjI5ZGEyOGRlOTVkZjE3YmE0My9wMDAxLmpwZw",
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/1",
      "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce",
      "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-1",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": "https://imgproxy.kitesheet.com/dLMVIMSb6PRRP2-1DcBuJQ8uL5NlqYwQZXGbpUB68xc/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9mMDcxNDczZjIzMThiZjI5ZGEyOGRlOTVkZjE3YmE0My9wMDAxLnBuZw",
      "thumbSrc": "https://imgproxy.kitesheet.com/7LgOt2r_DA0cYgv_Fkfs_N--cl9fukmBTD1w-68QEkc/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9mMDcxNDczZjIzMThiZjI5ZGEyOGRlOTVkZjE3YmE0My9wMDAxLmpwZw",
      "thumbSrcAlt": "https://imgproxy.kitesheet.com/gb9_H65hqG8JJhRFJMt8ZD-SQEcYPX4m91LeGxh2DSg/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9mMDcxNDczZjIzMThiZjI5ZGEyOGRlOTVkZjE3YmE0My9wMDAxLnBuZw"
    },
    {
      "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce",
      "docSlug": "f071473f2318bf29da28de95df17ba43",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 2,
      "slideType": "appendix_disclosure",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/2",
      "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce",
      "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-2",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce",
      "docSlug": "f071473f2318bf29da28de95df17ba43",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 3,
      "slideType": "thesis_headline",
      "function": "present_solution",
      "notes": "The slide uses a process-flow structure to connect the technology platform (LNCs) to a lead asset (MAT2203) and future pipeline expansion.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/3",
      "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce",
      "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-3",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce",
      "docSlug": "f071473f2318bf29da28de95df17ba43",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 4,
      "slideType": "roadmap",
      "function": "show_traction",
      "notes": "The slide uses a Gantt-style visualization to show the development stage of various programs.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/4",
      "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce",
      "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-4",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce",
      "docSlug": "f071473f2318bf29da28de95df17ba43",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 5,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a combination of molecular diagrams and bulleted lists to explain the mechanism and benefits of the LNC technology.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/5",
      "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce",
      "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-5",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 8,
          "from": 5,
          "beatId": "f7554ad4-4be1-4bca-b387-fb91d33ad3f6",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Product",
          "beatSlug": "sequoia-pitch-product",
          "evidence": "Lipid Nanocrystals (LNCs): A Clinically Validated Intracellular Delivery Platform",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce",
      "docSlug": "f071473f2318bf29da28de95df17ba43",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 6,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "Technical scientific slide detailing the mechanism of action for a drug delivery platform.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/6",
      "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce",
      "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-6",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 8,
          "from": 5,
          "beatId": "f7554ad4-4be1-4bca-b387-fb91d33ad3f6",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Product",
          "beatSlug": "sequoia-pitch-product",
          "evidence": "Lipid Nanocrystals (LNCs): A Clinically Validated Intracellular Delivery Platform",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce",
      "docSlug": "f071473f2318bf29da28de95df17ba43",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 7,
      "slideType": "comparison_table",
      "function": "compare_peers",
      "notes": "The LNC column is highlighted in light yellow to emphasize the company's proprietary technology.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/7",
      "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce",
      "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-7",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 8,
          "from": 5,
          "beatId": "f7554ad4-4be1-4bca-b387-fb91d33ad3f6",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Product",
          "beatSlug": "sequoia-pitch-product",
          "evidence": "Lipid Nanocrystals (LNCs): A Clinically Validated Intracellular Delivery Platform",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce",
      "docSlug": "f071473f2318bf29da28de95df17ba43",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 8,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/8",
      "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce",
      "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-8",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 8,
          "from": 5,
          "beatId": "f7554ad4-4be1-4bca-b387-fb91d33ad3f6",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Product",
          "beatSlug": "sequoia-pitch-product",
          "evidence": "Lipid Nanocrystals (LNCs): A Clinically Validated Intracellular Delivery Platform",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce",
      "docSlug": "f071473f2318bf29da28de95df17ba43",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 9,
      "slideType": "why_now",
      "function": "argue_timing",
      "notes": "Uses authority-citation to establish urgency and market relevance.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/9",
      "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce",
      "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-9",
      "loopMatches": [
        {
          "to": 16,
          "from": 9,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "4e8350fd-f8e5-46e3-b847-1504c590f092",
          "evidence": "The Growing Threat of Invasive Fungal Infections (IFIs) and High Unmet Medical Need in Treatment of Invasive Aspergillosis (IA)",
          "position": 0,
          "objective": "Highlight the high unmet medical need in treatment of invasive aspergillosis (IA)",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 9,
          "from": 9,
          "beatId": "01f1fbbd-65e1-46cb-a505-f301afa00929",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Problem",
          "beatSlug": "sequoia-pitch-problem",
          "evidence": "The growing threat of invasive fungal infections (IFIs)",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce",
      "docSlug": "f071473f2318bf29da28de95df17ba43",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 10,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "Uses a 'Before-After-Bridge' style logic (Characteristics - Limitations = Unlocked Potential).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/10",
      "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce",
      "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-10",
      "loopMatches": [
        {
          "to": 16,
          "from": 9,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "4e8350fd-f8e5-46e3-b847-1504c590f092",
          "evidence": "The Growing Threat of Invasive Fungal Infections (IFIs) and High Unmet Medical Need in Treatment of Invasive Aspergillosis (IA)",
          "position": 0,
          "objective": "Highlight the high unmet medical need in treatment of invasive aspergillosis (IA)",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 10,
          "from": 10,
          "beatId": "eb36bd20-6675-4634-9767-d6b9d233cfe8",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "MAT2203: Unlocking the Full Potential of Amphotericin B",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce",
      "docSlug": "f071473f2318bf29da28de95df17ba43",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 11,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide uses a process flow diagram to map clinical outcomes to specific data points.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/11",
      "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce",
      "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-11",
      "loopMatches": [
        {
          "to": 16,
          "from": 9,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "4e8350fd-f8e5-46e3-b847-1504c590f092",
          "evidence": "The Growing Threat of Invasive Fungal Infections (IFIs) and High Unmet Medical Need in Treatment of Invasive Aspergillosis (IA)",
          "position": 0,
          "objective": "Highlight the high unmet medical need in treatment of invasive aspergillosis (IA)",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce",
      "docSlug": "f071473f2318bf29da28de95df17ba43",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 12,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "This is a credibility-building slide showcasing academic validation of the company's technology.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/12",
      "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce",
      "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-12",
      "loopMatches": [
        {
          "to": 16,
          "from": 9,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "4e8350fd-f8e5-46e3-b847-1504c590f092",
          "evidence": "The Growing Threat of Invasive Fungal Infections (IFIs) and High Unmet Medical Need in Treatment of Invasive Aspergillosis (IA)",
          "position": 0,
          "objective": "Highlight the high unmet medical need in treatment of invasive aspergillosis (IA)",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce",
      "docSlug": "f071473f2318bf29da28de95df17ba43",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 13,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a human silhouette as a central anchor to map specific clinical indications to anatomical locations.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/13",
      "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce",
      "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-13",
      "loopMatches": [
        {
          "to": 16,
          "from": 9,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "4e8350fd-f8e5-46e3-b847-1504c590f092",
          "evidence": "The Growing Threat of Invasive Fungal Infections (IFIs) and High Unmet Medical Need in Treatment of Invasive Aspergillosis (IA)",
          "position": 0,
          "objective": "Highlight the high unmet medical need in treatment of invasive aspergillosis (IA)",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce",
      "docSlug": "f071473f2318bf29da28de95df17ba43",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 14,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Focuses on patients who failed or could not tolerate standard azole or IV Amphotericin B therapies.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/14",
      "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce",
      "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-14",
      "loopMatches": [
        {
          "to": 16,
          "from": 9,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "4e8350fd-f8e5-46e3-b847-1504c590f092",
          "evidence": "The Growing Threat of Invasive Fungal Infections (IFIs) and High Unmet Medical Need in Treatment of Invasive Aspergillosis (IA)",
          "position": 0,
          "objective": "Highlight the high unmet medical need in treatment of invasive aspergillosis (IA)",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce",
      "docSlug": "f071473f2318bf29da28de95df17ba43",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 15,
      "slideType": "other",
      "function": "illustrate_case",
      "notes": "The slide uses a timeline diagram combined with two line charts to demonstrate clinical efficacy and safety.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/15",
      "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce",
      "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-15",
      "loopMatches": [
        {
          "to": 16,
          "from": 9,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "4e8350fd-f8e5-46e3-b847-1504c590f092",
          "evidence": "The Growing Threat of Invasive Fungal Infections (IFIs) and High Unmet Medical Need in Treatment of Invasive Aspergillosis (IA)",
          "position": 0,
          "objective": "Highlight the high unmet medical need in treatment of invasive aspergillosis (IA)",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce",
      "docSlug": "f071473f2318bf29da28de95df17ba43",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 16,
      "slideType": "pain_points",
      "function": "frame_problem",
      "notes": "The slide highlights both the clinical urgency and the commercial orphan disease opportunity.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/16",
      "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce",
      "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-16",
      "loopMatches": [
        {
          "to": 16,
          "from": 9,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "4e8350fd-f8e5-46e3-b847-1504c590f092",
          "evidence": "The Growing Threat of Invasive Fungal Infections (IFIs) and High Unmet Medical Need in Treatment of Invasive Aspergillosis (IA)",
          "position": 0,
          "objective": "Highlight the high unmet medical need in treatment of invasive aspergillosis (IA)",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce",
      "docSlug": "f071473f2318bf29da28de95df17ba43",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 17,
      "slideType": "context",
      "function": "plan_implementation",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/17",
      "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce",
      "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-17",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce",
      "docSlug": "f071473f2318bf29da28de95df17ba43",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 18,
      "slideType": "appendix_methodology",
      "function": "plan_implementation",
      "notes": "The slide uses a process flow diagram to illustrate the clinical trial methodology.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/18",
      "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce",
      "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-18",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce",
      "docSlug": "f071473f2318bf29da28de95df17ba43",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 19,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "Uses a combination of an equation-style value proposition and a chevron-based process/timeline diagram.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/19",
      "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce",
      "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-19",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce",
      "docSlug": "f071473f2318bf29da28de95df17ba43",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 20,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/20",
      "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce",
      "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-20",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce",
      "docSlug": "f071473f2318bf29da28de95df17ba43",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 21,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide uses a matrix-like structure to map disease areas (Infection, Inflammation, Oncology) to specific animal models and clinical indications.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/21",
      "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce",
      "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-21",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce",
      "docSlug": "f071473f2318bf29da28de95df17ba43",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 22,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Data presented as a multi-panel chart comparing Uninfected, Infected Untreated, SQ Remdesivir, and Oral LNC-Remdesivir groups.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/22",
      "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce",
      "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-22",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce",
      "docSlug": "f071473f2318bf29da28de95df17ba43",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 23,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The chart demonstrates high uptake efficiency of LNC-formulated oligos over time across different cell types.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/23",
      "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce",
      "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-23",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce",
      "docSlug": "f071473f2318bf29da28de95df17ba43",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 24,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The chart shows dose-dependent inhibition; LNC formulations consistently outperform Taxol.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/24",
      "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce",
      "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-24",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce",
      "docSlug": "f071473f2318bf29da28de95df17ba43",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 25,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "The slide demonstrates that oral LNC-docetaxel is as effective as IV docetaxel with no significant side effects.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/25",
      "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce",
      "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-25",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}